In patients with advanced triple negative breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan ...
Phesi’s report of the world’s most-studied diseases has become a holiday tradition, and this year’s list features few surprises. Breast cancer took the top spot for the fifth year in a row, and the ...
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC is also more likely to metastasize, or travel through the bloodstream ...
DEWALT, a Stanley Black & Decker brand and relentless innovator for jobsite professionals, today announced in collaboration ...
Beyond The Gates preview for 2026 reveals that Anita Dupree (Tamara Tunie) was diagnosed with Triple Negative Breast Cancer. Anita and her husband Vernon Dupree (Clifton Davis) are trying to gain some ...
The Manila Times on MSN
UP chemists develop hybrid molecules that may halt metastasis
CHEMISTS from the University of the Philippines (UP) Diliman have synthesized a new class of hybrid molecules that may help limit the spread of cancer cells by targeting a key enzyme involved in tumor ...
5don MSN
Scientists Develop Blood Test That Predicts The Best Personalised Treatment For Breast Cancer
Scientists have now developed a DNA blood test that can predict how well patients with breast cancer will respond to ...
Exclusive: DNA test means patients could be offered most effective treatment first, boosting their chances of beating the disease ...
Outside the JPM Healthcare Conference, Thomas Clozel, cofounder and CEO of Owkin, sat down with MobiHealthNews to discuss how ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its ...
Next-generation therapeutic vaccines company also welcomes industry veteran Eric Halioua to board, as executive chairman Lead candidate ErVac01 is a cancer vaccine targeting novel tumor antigens ...
Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results